Detalhe da pesquisa
1.
Impaired CaV1.2 inactivation reduces the efficacy of calcium channel blockers in the treatment of LQT8.
J Mol Cell Cardiol
; 173: 92-100, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36272554
2.
Histone variant HTZ1 shows extensive epistasis with, but does not increase robustness to, new mutations.
PLoS Genet
; 9(8): e1003733, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23990806
3.
CaV1.2 channelopathic mutations evoke diverse pathophysiological mechanisms.
J Gen Physiol
; 154(11)2022 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36167061